Peroperative intracameral cefuroxime for cataract surgery

Download Report

Transcript Peroperative intracameral cefuroxime for cataract surgery

Peroperative intracameral
cefuroxime for cataract
surgery
Cholevík D., Mašek P.
University Hospital Ostrava
Czech Republic
ASCRS Chicago, 2008
Group

from May 2006 to February 2008

4498 cataract surgeries

two Super High Volume Surgeons
ASCRS Chicago, 2008
Pre-operative

Maxitrol gtt

topical anaestesia

povidine-iodine 5%
ASCRS Chicago, 2008
Surgery

2,8 mm CCI

standard phacoemulsification

foldable IOL implantation

1 mg cefuroxime intracameral
ASCRS Chicago, 2008
Post-operative


Maxitrol gtt 5x /d for 1/w
patients follow up – 1, 7, 14 and 30th day
after surgery
ASCRS Chicago, 2008
Results



4498 cataract surgeries
no postroperative inflammation
complications
0% postoperative endoftalmitis
ASCRS Chicago, 2008
Conclusions

We recommend intracameral
cefuroxime as a standard procedure
of modern phacoemulsification
cataract surgery
ASCRS Chicago, 2008
Appendix

ESCRS Guidelines on prevention, investigation
and management of post-operative
endophthalmitis
(Version 1, July 2005)
(Version 2, August 2007)
ISBN 0-9550988-0-7
ASCRS Chicago, 2008